DNA methylation markers for diagnosis and prognosis of common cancers

Proceedings of the National Academy of Sciences of the United States of America

Volumn 114, Issue 28, 2017, Pages 7414-7419

  Hao, Xiaoke ^a   Luo, Huiyan ^b,c   Krawczyk, Michal ^c   Wei, Wei ^b,c   Wang, Wenqiu ^c,d   Wang, Juan ^a   Flagg, Ken ^c   Hou, Jiayi ^c   Zhang, Heng ^e   Yi, Shaohua ^c   Jafari, Maryam ^c   Lin, Danni ^c   Chung, Christopher ^c   Caughey, Bennett A ^c   Li, Gen ^f   Dhar, Debanjan ^g   Shi, William ^c   Zheng, Lianghong ^f   Hou, Rui ^f   Zhu, Jie ^c   Zhao, Liang ^f   Fu, Xin ^c   Zhang, Edward ^c   Zhang, Charlotte ^c   Zhu, Jian Kang ^e   Karin, Michael ^g   Xu, Rui Hua ^b   Zhang, Kang ^c,h   more..

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d SHANGHAI FIRST PEOPLE S HOSPITAL   (China)

^e Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

^f Guangzhou KangRui Biological Pharmaceutical Technology Company Ltd   (China)

^g San Diego   (United States)

^h VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

Cancer diagnosis; Cancer prognosis; DNA methylation; Gene expression survival analysis

Indexed keywords

TUMOR MARKER;

ALLELE; ARTICLE; CANCER DIAGNOSIS; CANCER PROGNOSIS; CANCER SURVIVAL; COLORECTAL CANCER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DNA METHYLATION; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER METASTASIS; LUNG METASTASIS; PREDICTIVE VALUE; PRIORITY JOURNAL; BREAST TUMOR; CASE CONTROL STUDY; COHORT ANALYSIS; COLON TUMOR; CPG ISLAND; FEMALE; GENETICS; KAPLAN MEIER METHOD; LIVER TUMOR; LUNG TUMOR; MALE; METASTASIS; MORTALITY; NEOPLASM; PROGNOSIS; RISK; TIME FACTOR;

ALLELES; BREAST NEOPLASMS; CASE-CONTROL STUDIES; COHORT STUDIES; COLONIC NEOPLASMS; CPG ISLANDS; DNA METHYLATION; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; LUNG NEOPLASMS; MALE; NEOPLASM METASTASIS; NEOPLASMS; PROGNOSIS; RISK; TIME FACTORS;

EID: 85023194321     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1703577114     Document Type: Article

References (18)

1. DeVita VT, et al. (2011) DeVita, Hellman, and Rosenberg's Cancer: Principles and Practice of Oncology (Lippincott Williams & Wilkins, Philadelphia), Ed 9.
2. Wang T, et al. (2015) Identification and characterization of essential genes in the human genome. Science 350:1096-1101.
3. Han L, et al. (2014) The Pan-Cancer analysis of pseudogene expression reveals biologically and clinically relevant tumour subtypes. Nat Commun 5:3963.
4. Akbani R, et al. (2014) A pan-cancer proteomic perspective on The Cancer Genome Atlas. Nat Commun 5:3887.
5. Jaenisch R, Bird A (2003) Epigenetic regulation of gene expression: How the genome integrates intrinsic and environmental signals. Nat Genet 33:245-254.
6. Vaissière T, Sawan C, Herceg Z (2008) Epigenetic interplay between histone modifications and DNA methylation in gene silencing. Mutat Res 659:40-48.
7. Egger G, Liang G, Aparicio A, Jones PA (2004) Epigenetics in human disease and prospects for epigenetic therapy. Nature 429:457-463.
8. Herman JG, Baylin SB (2003) Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 349:2042-2054.
9. Feinberg AP, Tycko B (2004) The history of cancer epigenetics. Nat Rev Cancer 4:143-153.
10. Kandoth C, et al. (2013) Mutational landscape and significance across 12 major cancer types. Nature 502:333-339.
11. Paez JG, et al. (2004) EGFR mutations in lung cancer: Correlation with clinical response to gefitinib therapy. Science 304:1497-1500.
12. Ogino S, et al.; Alliance for Clinical Trials in Oncology (2013) Predictive and prognostic analysis of PIK3CA Mutation in Stage III Colon Cancer Intergroup Trial. J Natl Cancer Inst 105:1789-1798.
13. Koboldt DC, et al. (2012) VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res 22:568-576.
14. Dees ND, et al. (2012) MuSiC: Identifying mutational significance in cancer genomes. Genome Res 22:1589-1598.
15. Smyth GK (2004) Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3:3.
16. Friedman J, Hastie T, Tibshirani R (2010) Regularization paths for generalized linear models via coordinate descent. J Stat Softw 33:1-22.
17. Yuan Y, et al. (2014) Assessing the clinical utility of cancer genomic and proteomic data across tumor types. Nat Biotechnol 32:644-652.
18. Lehmann-Werman R, et al. (2016) Identification of tissue-specific cell death using methylation patterns of circulating DNA. Proc Natl Acad Sci USA 113:E1826-E1834.